Dolby Laboratories (NYSE:DLB) Updates Q1 2026 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its first quarter 2026 earnings guidance on Tuesday. The company provided EPS guidance of 0.790-0.940 for the period, compared to the consensus EPS estimate of 1.010. The company issued revenue guidance of $315.0 million-$345.0 million, compared to the consensus revenue estimate of $365.1 million. Dolby Laboratories also updated its FY 2026 guidance to 4.190-4.340 EPS.

Dolby Laboratories Stock Performance

NYSE DLB traded up $0.58 during trading hours on Tuesday, reaching $65.13. The company’s stock had a trading volume of 904,009 shares, compared to its average volume of 455,687. The company’s 50-day moving average is $69.07 and its two-hundred day moving average is $72.58. Dolby Laboratories has a fifty-two week low of $64.02 and a fifty-two week high of $89.66. The stock has a market cap of $6.24 billion, a PE ratio of 23.86 and a beta of 0.97.

Analyst Ratings Changes

Several research firms have recently commented on DLB. Baird R W upgraded shares of Dolby Laboratories to a “hold” rating in a research report on Friday, September 5th. Barrington Research reiterated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 12th. Tigress Financial boosted their price target on Dolby Laboratories from $112.00 to $114.00 and gave the stock a “buy” rating in a report on Friday, August 15th. Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research report on Thursday. Finally, Robert W. Baird assumed coverage on Dolby Laboratories in a research note on Friday, September 5th. They set a “neutral” rating and a $74.00 price objective on the stock. Three investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Dolby Laboratories presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.75.

Insider Buying and Selling at Dolby Laboratories

In other Dolby Laboratories news, SVP Shriram Revankar sold 7,000 shares of the firm’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $74.92, for a total value of $524,440.00. Following the sale, the senior vice president directly owned 70,435 shares of the company’s stock, valued at approximately $5,276,990.20. This trade represents a 9.04% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Kevin J. Yeaman sold 25,000 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 14th. The shares were sold at an average price of $68.87, for a total value of $1,721,750.00. Following the completion of the sale, the chief executive officer owned 114,725 shares of the company’s stock, valued at $7,901,110.75. This trade represents a 17.89% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold 57,000 shares of company stock worth $4,037,690 in the last 90 days. Insiders own 38.39% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

Several hedge funds have recently modified their holdings of the stock. AQR Capital Management LLC grew its holdings in Dolby Laboratories by 51.8% in the second quarter. AQR Capital Management LLC now owns 1,736,260 shares of the electronics maker’s stock valued at $128,935,000 after purchasing an additional 592,282 shares during the period. State Street Corp grew its stake in shares of Dolby Laboratories by 8.7% during the 2nd quarter. State Street Corp now owns 2,261,059 shares of the electronics maker’s stock valued at $167,906,000 after buying an additional 180,072 shares during the period. Goldman Sachs Group Inc. grew its stake in shares of Dolby Laboratories by 218.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,574 shares of the electronics maker’s stock valued at $20,043,000 after buying an additional 171,288 shares during the period. Millennium Management LLC raised its position in shares of Dolby Laboratories by 349.4% in the 3rd quarter. Millennium Management LLC now owns 217,779 shares of the electronics maker’s stock worth $15,761,000 after buying an additional 169,319 shares during the period. Finally, Squarepoint Ops LLC boosted its holdings in Dolby Laboratories by 37.2% in the third quarter. Squarepoint Ops LLC now owns 516,700 shares of the electronics maker’s stock valued at $37,394,000 after acquiring an additional 140,201 shares during the last quarter. 58.56% of the stock is owned by institutional investors and hedge funds.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.